ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 247 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 1.36 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2019 | $2,145,000 | +178.2% | 50,130 | +133.9% | 0.11% | +171.8% |
| Q3 2019 | $771,000 | +34.1% | 21,430 | -0.5% | 0.04% | +18.2% |
| Q2 2019 | $575,000 | -58.5% | 21,530 | -58.3% | 0.03% | -60.2% |
| Q1 2019 | $1,386,000 | -0.5% | 51,630 | -43.4% | 0.08% | +45.6% |
| Q2 2018 | $1,393,000 | -22.4% | 91,230 | +53.1% | 0.06% | -27.8% |
| Q4 2017 | $1,794,000 | +415.5% | 59,605 | +392.6% | 0.08% | +276.2% |
| Q4 2016 | $348,000 | -92.0% | 12,100 | -92.2% | 0.02% | -89.2% |
| Q1 2016 | $4,351,000 | +1541.9% | 155,645 | +1992.8% | 0.20% | +1400.0% |
| Q4 2015 | $265,000 | -91.4% | 7,437 | -92.0% | 0.01% | -88.6% |
| Q3 2015 | $3,091,000 | +726.5% | 93,469 | +692.9% | 0.11% | +714.3% |
| Q4 2014 | $374,000 | – | 11,788 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
| GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
| EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
| NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
| Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
| Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
| Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
| GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |